Our IV Therapy is not a one-size-fits-all solution
Monitoring Requirements: Regular check-ins with your Healthcare Provider may be required to evaluate treatment progress and adjust dosage or frequency as needed
Beyond pulmonary applications, luteolin has shown efficacy in liver fibrosis models, inhibiting hepatic stellate cell proliferation by targeting AKT/mTOR/p70S6K and TGFB/Smad signaling pathways, indicating that the anti-fibrotic action may involve cross-talk between these two signaling pathways
Currently, an ongoing phase III, multicenter, randomized, sham-controlled, double-blind trial is evaluating AT-04s efficacy and safety for endometriosis-related pain (dysmenorrhea, dyspareunia, chronic pelvic pain), with the primary outcome being the change in Numeric Rating Scale score at 16 weeks (36)
Before clinical application, the safety of natural products should be a primary concern
Satisfied Really happy with the boost of energy Everything is good Energy has approved Works great
